Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
01/2013
01/02/2013CN102850279A Preparation method of 6, 7-bi (2-methoxyl ethyoxyl) quinazoline-4-ketone
01/02/2013CN102250015B Penta-substituted tetrahydropyridine capable of carrying out aggregation-induced emission as well as preparation method and application thereof
01/02/2013CN102206187B New synthetic method for 6-benzyl-1-ethoxymethyl-5-isopropyluracil (Emivirine) and analogues thereof
01/02/2013CN101830889B 嘧啶衍生物 Pyrimidine derivatives
01/02/2013CN101675739B Synergistic herbicidal compositions
01/02/2013CN101365681B Iminopropene compound and use thereof
01/02/2013CN101316843B Aminopyrimidines useful as kinase inhibitors
01/01/2013US8344160 Pyrrolone melanin concentrating hormone receptor-1 antagonists
01/01/2013US8343990 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
01/01/2013US8343988 Inhibitors of histone deacetylase
01/01/2013US8343987 Heterocyclic derivatives
01/01/2013US8343986 Matrix metalloproteinase inhibitors
01/01/2013US8343984 Protein kinase inhibitor; purity; polymorphism
01/01/2013US8343983 Substituted pyrazolo-pyrimidine compounds
01/01/2013US8343982 Bicyclic heterocyclic compounds pharmaceutical compositions containing these compounds, their use and process for preparing the same
01/01/2013US8343980 Quinazoles useful as modulators of ion channels
12/2012
12/27/2012WO2012176218A1 Process for preparing rosuvastatin calcium through novel amine salt
12/27/2012WO2012136834A9 Pyrimidine derivatives for the treatment of viral infections
12/27/2012WO2012135641A3 Aurora kinase inhibitors and methods of making and using thereof
12/27/2012US20120329784 Compounds and methods
12/27/2012US20120329778 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
12/27/2012US20120329649 Pesticidal compositions and processes related thereto
12/27/2012US20120328599 Inhibitors of receptor tyrosine kinases (rtk) and methods of use thereof
12/26/2012EP2537832A1 Method for preparing (e)-methyl 2-[2-(6-chloropyrimidin-4-yloxy)phenyl]-3-methoxyacrylate
12/26/2012EP2537830A1 Compounds and compositions as protein kinase inhibitors
12/26/2012EP2536696A1 Pyrimidine derivatives
12/26/2012EP2536695A1 Improved processes for preparing ticagrelor intermediate, 4,6-dichloro-5-nitro-2-(propylthio)pyrimidine
12/26/2012EP2536694A1 Glycine sulfonamides for use as inhibitors of diacylglycerol lipase
12/26/2012EP2536693A1 Substituted 2-imidazolidones and analogs
12/26/2012EP2536690A1 Multifunctional radical quenchers and their use
12/26/2012EP2536689A1 Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain
12/26/2012CN102838590A Amino quinazoline derivative and application thereof in preparation of antineoplastic drugs
12/26/2012CN102838550A Quinolinylcrotyl compound and its application in preparation of anti-malignant tumor drugs
12/26/2012CN102838549A New class of 1,5,6-substituted pyrimidine derivatives with anti-HIV virus effects
12/26/2012CN101932564B Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
12/26/2012CN101304978B Quinazoline derivatives as a multiplex inhibitor, pharmaceutical composition and uses thereof
12/25/2012US8338597 Pyridones useful as inhibitors of kinases
12/25/2012US8338438 Polymorph forms of 4-anilinoquinazoline derivatives, the preparation methods and uses thereof
12/25/2012US8338433 Tyrosine kinase inhibitors as anti-kinetoplastid agents
12/25/2012US8338423 Compositions for the treatment of hyperphenylalaninemia
12/20/2012WO2012172564A1 Process for preparation of rosuvastatin calcium
12/20/2012WO2012171484A1 Substituted cyanoaniline compounds, preparation and use thereof
12/20/2012US20120323005 Process For The Preparation Of Amide Intermediates And Their Use Thereof
12/20/2012US20120322878 Polycationic Compounds And Uses Thereof
12/20/2012US20120322802 Novel 2, 4-pyrimidine derivatives and use thereof
12/20/2012US20120322801 Heterocyclic amides as rock inhibitors
12/20/2012US20120322795 Biarylamide inhibitors of leukotriene production
12/20/2012US20120322761 Heterocyclic cetp inhibitors
12/20/2012US20120319044 Organic ionic phenylpyrimidine compounds and displays formed thereof
12/19/2012CN102827087A Synthetic method of erlotinib
12/19/2012CN102827086A Preparation method for 4-chloro-6,7-bis(2-methoxyethoxy)quinazoline
12/19/2012CN102827085A Preparation method for 2,4,5-trichloropyrimidine compound
12/19/2012CN102827072A Substituted nitroaniline compound and its application
12/19/2012CN102827071A Compound containing aminobenzonitrile and application thereof
12/19/2012CN101279952B Method for preparing 1,3-dimethyl alkyleneurea by methylation by step
12/19/2012CN101068794B Quinazolines useful as modulators of ion channels
12/18/2012US8334383 Regioselective preparation of substituted pyrimidines
12/18/2012US8334316 Substituted organosulfur compounds and methods of using thereof
12/18/2012US8334296 2,4-pyrimidinediamine compounds and their uses
12/18/2012US8334293 P70 S6 kinase inhibitor and EGFR inhibitor combination therapy
12/18/2012US8334292 Pyrimidine compounds and methods of making and using same
12/18/2012US8334291 Aliphatically substituted pyrazolopyridines, and the use thereof
12/18/2012US8334290 CETP inhibitors
12/18/2012CA2671776C Gal3 receptor antagonists for the treatment of depression
12/18/2012CA2536576C Derivatives of hydroxamic acid as metalloproteinase inhibitors
12/18/2012CA2533812C Substituted cycloalkylidene compounds
12/13/2012WO2012170976A2 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
12/13/2012WO2012170647A1 Process for the preparation of etravirine and intermediates in the synthesis thereof
12/13/2012WO2012167406A1 Method for preparing optically pure (+)-ambrisentan and (+)-darusentan
12/13/2012US20120316340 Use of metal-accumulating plants for the preparation of catalysts that can be used in chemical reactions
12/13/2012US20120316171 Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer
12/13/2012US20120316169 2-aryl-propionamide derivatives useful as bradykinin receptor antagonists and pharmaceutical compositions containing them
12/13/2012US20120315230 Cosmetic composition, cosmetic treatment method and compound
12/13/2012US20120315217 Inverse agonists and neutral antagonists for the tsh receptor
12/13/2012US20120313041 Four-ring compound having a plurality of cf2o bonding groups, liquid crystal composition and liquid crystal display device
12/13/2012CA2833771A1 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
12/12/2012EP2532653A1 Benzo[1,2,4]triazines as protein kinase modulators
12/12/2012EP2532643A1 IRE-1A Inhibitors
12/12/2012EP2531499A2 Process for preparing voriconazole by using new intermediates
12/12/2012CN102816124A Hydroxylated and methoxylated cyclopenta [D] pyrimidines as AKT protein kinase inhibitors
12/12/2012CN102816123A Preparation method for cytosine
12/12/2012CN102816122A Preparation method of pyrimethanil
12/12/2012CN102816114A Preparation method of HMG-CoA reductase inhibitor
12/12/2012CN102199127B Method for preparing azoxystrobin
12/12/2012CN102190629B Method for preparing azoxystrobin from hydrocyanic acid in acrylonitrile waste gas
12/12/2012CN102126955B Processes for the preparation of azoxystrobin using DABCO as a catalyst and novel intermediates used in the processes
12/11/2012US8329902 Optically pure dihydropyrimidine compounds and their uses for the preparation of a medicament for treatment and prevention of viral diseases
12/11/2012US8329901 4,6-disubstitued pyrimidines useful as kinase inhibitors
12/11/2012US8329900 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
12/11/2012US8329898 Pyrido[3,2-h]quinazolines and/or 5,6-dihydro derivatives thereof, a method for the production thereof and doped organic semiconductor material containing these
12/11/2012US8329745 Small molecule inhibitors of ghrelin O-acyltransferase
12/11/2012US8329713 Fused ring heterocycles as potassium channel modulators
12/11/2012US8329709 5H-cyclopenta[D]pyrimidines as AKT protein kinase inhibitors
12/11/2012US8329708 1,3,6-substituted indole derivatives having inhibitory activity for protein kinase
12/11/2012US8329691 Amide compounds and use of the same
12/11/2012US8329390 Detection of transmembrane potentials using N,N,N′-trialkyl thiobarbituric acid-derived polymethine oxonols
12/11/2012CA2647819C Phenylcyclohexyl derivatives as dgat1 inhibitors
12/11/2012CA2571722C Phenyl derivatives comprising an acetylene group
12/11/2012CA2515780C Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
12/06/2012WO2012167046A1 Novel immune system modulators
1 ... 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 ... 427